Undergraduate education

University of Wisconsin-Madison, BS, 1994

Years in MSTP



Medical microbiology and immunology, 1998


Gerald Byrne, PhD

Thesis title

Interactions Between Chlamydia Pneumoniae and Mononuclear Phagocytes in the Pathogenesis of Atherosclerosis


Ophthalmology, Harvard University


MBA, MIT School of Management

Current position

President and CEO, Cartesian Therapeutics

View profile

PhD publications

Byrne GI, Kalayoglu MV. Chlamydia pneumoniae and atherosclerosis: links to the disease process. Am Heart J. 1999 Nov;138(5 Pt 2):S488-90. PMID: 10539855. 

Kalayoglu MV, Hoerneman B, LaVerda D, Morrison SG, Morrison RP, Byrne GI. Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis. 1999 Sep;180(3):780-90. PMID: 10438367.

Kalayoglu MV, Miranpuri GS, Golenbock DT, Byrne GI. Characterization of low-density lipoprotein uptake by murine macrophages exposed to Chlamydia pneumoniae. Microbes Infect. 1999 May;1(6):409-18. PMID: 10602673.

LaVerda D, Kalayoglu MV, Byrne GI. Chlamydial heat shock proteins and disease pathology: new paradigms for old problems? Infect Dis Obstet Gynecol. 1999;7(1-2):64-71. Review. PMID: 10231012; PMCID: PMC1784717.

Kalayoglu MV, Byrne GI. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun. 1998 Nov;66(11):5067-72. PMID: 9784505; PMCID: PMC108631.

Kalayoglu MV, Byrne GI. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis. 1998 Mar;177(3):725-9. PMID: 9498454.

Meyer KC, Arend RA, Kalayoglu MV, Rosenthal NS, Byrne GI, Brown RR. Tryptophan metabolism in chronic inflammatory lung disease. J Lab Clin Med. 1995 Dec;126(6):530-40. PMID: 7490512.

Malone DG, Dolan PW, Brown RR, Kalayoglu MV, Arend RA, Byrne GI, Ozaki Y. Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells. J Rheumatol. 1994 Jun;21(6):1011-9. PMID: 7523670.

Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI, Mansour S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol. 2003 Apr;121(4):478-82. PMID: 12695244.

Kalayoglu MV, Libby P, Byrne GI. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA. 2002 Dec 4;288(21):2724-31. PMID: 12460096.

Kalayoglu MV, Perkins BN, Byrne GI. Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells. Microbes Infect. 2001 Oct;3(12):963-9. PMID: 11580983.

Byrne GI, Skarlotos SI, Grunfeld C, Kalayoglu MV, Libby P, Saikku P, Summersgill JT, Wyrick P. Collaborative multidisciplinary workshop report: interface of lipid metabolism, atherosclerosis, and Chlamydia infection. J Infect Dis. 2000 Jun;181 Suppl 3:S490-1. PMID: 10839745.

Kalayoglu MV, Indrawati, Morrison RP, Morrison SG, Yuan Y, Byrne GI. Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions. J Infect Dis. 2000 Jun;181 Suppl 3:S483-9. PMID: 10839744.

Mahdi OS, Byrne GI, Kalayoglu M. Emerging strategies in the diagnosis prevention and treatment of chlamydial infections. Expert Opinion on Therapeutic Patents. 2011 Aug;11(8):1253-1265.

Kalayoglu MV, Myint M, Byrne GI. Reply. J Infect Dis. 2000 May;181(5):1869-70. PMID: 10823810.